Label: AMOXI-DROP- amoxicillin suspension

  • NDC Code(s): 54771-6036-1, 54771-6036-6
  • Packager: Zoetis Inc.
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Animal Drug Application

Drug Label Information

Updated June 4, 2020

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Amoxi-Drop 

    (amoxicillin for oral suspension), USP

    For veterinary oral suspension

    For use in dogs and cats

  • CAUTION

    Federal law restricts this drug to use by or on the order of a licensed veterinarian.

  • DESCRIPTION

    Amoxi-Drop (amoxicillin for oral suspension), USP is a semisynthetic antibiotic with a broad spectrum of activity. It provides bactericidal activity against a wide range of common gram-positive and gram-negative pathogens. Chemically, it is D(-)-α-amino-p-hydroxybenzyl penicillin trihydrate.

  • CLINICAL PHARMACOLOGY

    Amoxi-Drop is stable in the presence of gastric acid and may be given without regard to meals. It is rapidly absorbed after oral administration. It diffuses readily into most body tissues and fluids with the exception of brain and spinal fluid, except when meninges are inflamed. Most of the amoxicillin is excreted unchanged in the urine.

    Amoxicillin is similar to ampicillin in its bactericidal action against susceptible organisms. It acts through the inhibition of biosynthesis of cell wall mucopeptide. In vitro and/or in vivo studies have demonstrated the susceptibility of most strains of the following gram-positive and gram-negative bacteria: α- and β-haemolytic streptococci, nonpenicillinase-producing staphylococci, Streptococcus faecalis, Escherichia coli, and Proteus mirabilis. Because it does not resist destruction by penicillinase, it is not effective against penicillinase-producing bacteria, particularly resistant staphylococci. All strains of Pseudomonas and most strains of Klebsiella and Enterobacter are resistant.

  • INDICATIONS

    Dogs

    Amoxi-Drop is indicated in the treatment of susceptible strains of the organisms causing the following infections:

    Respiratory tract infections (tonsillitis, tracheobronchitis) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Proteus mirabilis.

    Genitourinary tract infections (cystitis) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Proteus mirabilis.

    Gastrointestinal tract infections (bacterial gastroenteritis) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Proteus mirabilis.

    Bacterial dermatitis due to Staphylococcus aureus, Streptococcus spp., and Proteus mirabilis.

    Soft tissue infections (abscesses, lacerations, and wounds) due to Staphylococcus aureus, Streptococcus spp., E. coli, and Proteus mirabilis.

    Cats

    Amoxi-Drop is indicated in the treatment of susceptible strains of the organisms causing the following infections:

    Upper respiratory tract infections due to Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., Haemophilus spp., E. coli, Pasteurella spp., and Proteus mirabilis.

    Genitourinary tract infections (cystitis) due to Staphylococcus aureus, Streptococcus spp., E. coli, Proteus mirabilis, and Corynebacterium spp.

    Gastrointestinal tract infections due to E. coli, Proteus spp., Staphylococcus spp., and Streptococcus spp.

    Skin and soft tissue infections (abscesses, lacerations, and wounds) due to Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., E. coli, and Pasteurella multocida.

  • CONTRAINDICATIONS

    The use of this drug is contraindicated in animals with a history of an allergic reaction to penicillin.

  • WARNINGS

    For use in dogs and cats only. Not for use in animals which are raised for food production.

  • ADVERSE REACTIONS

    Amoxicillin is a semisynthetic penicillin and has the potential for producing allergic reactions. If an allergic reaction occurs, administer epinephrine and/or steroids.

  • DOSAGE AND ADMINISTRATION

    Dogs

    The recommended dosage is 5 mg/lb of body weight. Administer twice daily for 5–7 days. Continue for 48 hours after all symptoms have subsided.

    Cats

    The recommended dosage is 50 mg (5–10 mg/lb). Administer once daily for 5–7 days. Continue for 48 hours after all symptoms have subsided.

    Directions for Mixing Oral Suspension:

    Add required amount of water (see following table) to the bottle and shake vigorously. Each mL of suspension will contain 50 mg of amoxicillin as the trihydrate.

    Bottle Size Amount of Water Required for Reconstitution
     15 mL 12 mL
     30 mL 23 mL

    Note: Any unused portion of the reconstituted suspension must be discarded after 14 days. After mixing, refrigeration preferable, but not required.

    Do Not Store Dry Powder at Temperatures Above 25°C (77°F)

  • HOW SUPPLIED

    Amoxi-Drop is supplied in 15-mL bottles containing 0.75 g and 30-mL bottles containing 1.5 g of amoxicillin activity. When reconstituted with required amount of water, each mL contains 50 mg of amoxicillin as the trihydrate.

  • SPL UNCLASSIFIED SECTION

    Approved by FDA under NADA # 055-085

    PRODUCT OF SPAIN

    zoetis

    Distributed by:
    Zoetis Inc.
    Kalamazoo, MI 49007

    Revised: February 2019
    P1518394

  • PRINCIPAL DISPLAY PANEL - 15 mL Label

    15 mL Label
  • PRINCIPAL DISPLAY PANEL - 30 mL Label

    30 mL Label
  • INGREDIENTS AND APPEARANCE
    AMOXI-DROP 
    amoxicillin suspension
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:54771-6036
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    AMOXICILLIN (UNII: 804826J2HU) (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9) AMOXICILLIN ANHYDROUS50 mg  in 1 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:54771-6036-130 mL in 1 BOTTLE, DROPPER
    2NDC:54771-6036-615 mL in 1 BOTTLE, DROPPER
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA05508501/28/1977
    Labeler - Zoetis Inc. (828851555)